Home/ Stocks/ ADVB

Advanced Biomed Inc. Common Stock

ADVB XNAS

$9.34 -0.11 (-1.17%) ▼ 15-min delayed

Open

$9.33

High

$9.44

Low

$9.10

Volume

66.5K

Market Cap

$15.42M

About Advanced Biomed Inc. Common Stock

Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.

Sector: SERVICES-MEDICAL LABORATORIES Employees: 31 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q3 2026	N/A	$-488,942	$-0.38
Q2 2026	N/A	$6.86M	$0.31
Q1 2026	N/A	$-386,901	$-0.02
FY 2025	N/A	$-3,258,969	$-0.16

Earnings & Analyst Ratings

Next Earnings: Tue, Nov 17, 2026

Calendar →

TickerDaily Coverage

ADVB Stock Up 52.3% Today: Advanced Biomed IPO Closes at $10.78

Market News Sarah Mitchell · Jul 22, 2026

Advanced Biomed Inc. Common Stock (ADVB) exploded 52.3% higher on Wednesday, July 22, 2026, closing...

View All Coverage →

Get ADVB Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Advanced Biomed Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.